Sydney Lepkin
👤 SpeakerAppearances Over Time
Podcast Appearances
New drugs typically cost a lot more in the U.S.
than they do in other countries.
And the Trump administration has been announcing deals with drug companies to try to even the playing field.
has a deal with another country, the U.K.,
The UK will increase the prices its health service pays for new medicines by 25% and will reduce rebates paid by drug makers.
That's according to the Office of the United States Trade Representative.
In exchange, UK drugs, drug ingredients and medical technology will be exempt from US tariffs for at least three years.
Novo Nordisk has been working on a pill containing the same active ingredient as Ozempic and Wegovi.
It's a higher dose than what's in type 2 diabetes pill Rebelsis and is instead aimed at patients with obesity.
Studies show the new pill's efficacy is similar to Wagovi's.
If approved, the company says it will offer a discounted price of $149 a month for people not using their health insurance.
That's part of a deal announced with the Trump administration earlier this year.
Novo Nordisk has not yet announced a sticker price for insurers yet, however.
And that is the price that will determine insurance coverage.
The company says it is working with other parts of the drug supply chain to improve access.
The new restructuring plan replaces one the Supreme Court rejected in 2024, finding that it would have shielded the Sackler family from future lawsuits.
This time around, members of the family can still be sued in civil court.